CRANBURY, N.J.--(BUSINESS WIRE)--Targeted Oncology™, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, announces the addition of Tennessee Oncology to their Strategic Alliance Partnership (SAP) program.
“We are so excited to be partnering with Tennessee Oncology,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of Targeted Oncology™. “They are one of the premier oncology specialty groups in the country, and we look forward to helping them disseminate information to improve cancer care for patients and their families.”
Tennessee Oncology is one of the nation’s largest community-based cancer care centers and is home to a leading clinical trial network. The institution strives to provide patients with access to high-quality cancer care and the expertise of clinical research, in their community and close to their homes. Tennessee Oncology is committed to advancing both the science of detection and targeted treatments and to making these advances available to every patient.
“Our longstanding mission is to provide the highest quality cancer care and access to cutting edge treatments for patients close to home. Our partnership with Targeted Oncology is perfectly aligned with this mission by improving provider access to continued education about the newest advancements in the delivery of personalized medicine, and then sharing these learnings across our network of over 70 oncologists caring for patients in the local communities where our patients live.”
The SAP program is constantly building a community of advocacy groups, medical associations and medical institutions to foster collaboration and an open exchange of information for the benefit of patients, their families and overall patient care. As part of this joint effort, Targeted Oncology™ will work with Tennessee Oncology to share exclusive content and information.
For more information about the Targeted Oncology™ SAP program, click here.
For more information about Tennessee Oncology, click here.
About Targeted Oncology™
TargetedOnc.com, the website for Targeted Oncology™, provides practicing oncologists with the latest news and insights on next-generation therapeutics and their molecular targets. As the field of oncology moves toward systemic biology and molecular aberrations, oncologists struggle to stay up to date with cancer therapeutics. Targeted Oncology™ provides breaking news and updates on this burgeoning field, focusing on the next stage of cancer development, cutting-edge therapies and biological targets. Content is organized by tumor type, news and conference coverage. Targeted Oncology™ is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.
About Tennessee Oncology
Tennessee Oncology, PLLC is one of the nation’s leading teams of cancer care specialists, nationally recognized for improving patient outcomes and driving quality of life innovation. In 2018 it created a partnership with OneOncology, a technology-powered, data-driven, alliance of America’s foremost community oncologists. Our comprehensive range of cancer care services includes specialized oncology nursing care, laboratory services, pharmacy, outpatient chemotherapy, PET/CT services, palliative care, patient and family education and financial support services. Founded in 1976, our unique vision, introducing patient-driven care with a clinical trial focus, propelled Tennessee Oncology to lead one of the largest, physician-owned, community oncology practices in the country. Currently over 95 physicians in more than 30 locations, share the privilege of serving adult cancer patients from South Central Kentucky through Middle Tennessee to Northwest Georgia. For a complete list of Physicians, locations and services please visit: www.tnoncology.com